Netabolics

Startup

Netabolics is a pioneering biotech company specializing in AI-driven biosimulation to decode the complexities of human biology. By integrating computational dynamical modeling with multiomics data, Netabolics enables precise identification and validation of novel biological target combinations for the development of real-world therapeutic breakthroughs.

Netabolics is driven by a mission to revolutionize drug discovery and biomedical research through biosimulation. Our vision is a future where computational modeling plays a central role in personalized medicine, pushing the boundaries of what is possible in the realm of how we understand and treat diseases.

At the core of Netabolics' approach is a genome-scale mechanistic biosimulation platform that models and dynamically simulates intricate biological networks in silico, predicting system-wide responses to genetic, environmental, and pharmacological interventions. Unlike traditional machine learning approaches, our scalable and disease-agnostic biosimulations provide explainable and biologically grounded predictions.

Our technology benefits a range of partners across the biomedical ecosystem. Pharmaceutical companies reduce R&D costs and failure rates by accelerating target validation and optimizing drug development pipelines. Biotech startups de-risk early-stage projects through predictive analytics for novel and repurposed drug combinations. Academic researchers gain access to advanced modeling to support hypothesis testing and exploration of complex biological systems.

website